M&A Deal Summary |
|
---|---|
Date | 2016-08-09 |
Target | Biomedical Structures |
Sector | Medical Products |
Buyer(s) | Confluent Medical |
Sellers(s) |
Ampersand Capital Partners
Symmetric Capital |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1991 |
Sector | Medical Products |
Confluent Medical is a contract manufacturer of Nitinol-based and balloon catheter medical devices. Confluent provides a broad range of capabilities including developing and manufacturing components, delivery systems, and finished devices for medical device OEMs in many of the fastest-growing healthcare subsectors, including neurovascular, structural heart, electrophysiology, aortic intervention, peripheral vascular, and ENT. Confluent Medical was founded in 1991 and is based in Scottsdale, Arizona.
DEAL STATS | # |
---|---|
Overall | 4 of 7 |
Sector (Medical Products) | 3 of 5 |
Type (Add-on Acquisition) | 4 of 6 |
State (Rhode Island) | 1 of 1 |
Country (United States) | 4 of 6 |
Year (2016) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-08-09 |
Modified Polymer Components
Sunnyvale, California, United States Modified Polymer Components, Inc. is specializes in the design, development, and manufacture of highly precise polymer components and assemblies. MPC’s extensive production capabilities enable it to perform secondary operations for all types of polymer tubing, including complex multilumen extrusions, to create ramps, tips, and almost any imaginable feature. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-02-08 |
Corpus Medical
Campbell, California, United States Corpus Medical, Inc. is a provider of high-quality consulting and manufacturing services for the development and commercialization of innovative intervention medical devices. Corpus Medical specializes in catheter technologies, assembly of fully packaged devices and medical implants. Corpus Medical was founded in 2009 and is based in Campbell, California. |
Buy | - |
Category | Growth Capital Firm |
---|---|
Founded | 1988 |
PE ASSETS | 3.0B USD |
Size | Large |
Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 28 of 55 |
Sector (Medical Products) | 8 of 14 |
Type (Add-on Acquisition) | 20 of 38 |
State (Rhode Island) | 1 of 1 |
Country (United States) | 28 of 51 |
Year (2016) | 6 of 9 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-08-09 |
Modified Polymer Components
Sunnyvale, California, United States Modified Polymer Components, Inc. is specializes in the design, development, and manufacture of highly precise polymer components and assemblies. MPC’s extensive production capabilities enable it to perform secondary operations for all types of polymer tubing, including complex multilumen extrusions, to create ramps, tips, and almost any imaginable feature. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-08-22 |
BioClinica
Princeton, New Jersey, United States Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market, for people around the world. Through deep medical, scientific, and technology expertise, the company provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica’s global team of life science experts serves more than 500 pharmaceutical, biotechnology, and device organizations including the top 20 biopharmaceutical companies and leading CROs through offices in North America, Europe, and Asia. Bioclinica was formed in 1990 and is based in Princeton, New Jersey. |
Sell | - |
Category | Private Equity Firm |
---|---|
Founded | 2007 |
PE ASSETS | 202M USD |
Size | Small |
Type | Sector Agnostic |
Symmetric Capital is a private equity firm that invests in profitable growth companies in the US and Canada. Symmetric seeks to invest $5 to $25 million to help fund shareholder liquidity needs, growth, acquisitions, or debt reduction. Symmetric will consider majority or minority positions and typically looks for market-leading companies owned by their founders, a family, or small partnership. Sectors of interest include business services, healthcare and life sciences, software, IT services, applied technology, industrial products, education, logistics and distribution, and consumer products. Symmetric was formed in 2007 and is based in Waltham, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 12 of 14 |
Sector (Medical Products) | 2 of 2 |
Type (Add-on Acquisition) | 10 of 11 |
State (Rhode Island) | 1 of 1 |
Country (United States) | 11 of 13 |
Year (2016) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-04-01 |
BioRx
Cincinnati, Ohio, United States BioRx LLC is a specialized pharmacy and infusion services provider that provides treatments for patients with ultra-orphan and rare, chronic diseases. |
Sell | $210M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-07-18 |
School Improvement Network
Midvale, Utah, United States School Improvement Network is an online professional learning and teacher effectiveness company and partners with schools, districts, and educators throughout the United States, Canada, and overseas to increase student achievement. |
Sell | - |